BACKGROUND: Diet is a major contributor to metabolic disease risk, but there is controversy as to whether increased incidences of diseases such as non-alcoholic fatty liver disease arise from consumption of saturated fats or free sugars. Here, we investigate whether a sub-set of triacylglycerols (TAGs) were associated with hepatic steatosis and whether they arise from de novo lipogenesis (DNL) from the consumption of carbohydrates. RESULTS: We conduct direct infusion mass spectrometry of lipids in plasma to study the association between specific TAGs and hepatic steatosis assessed by ultrasound and fatty liver index in volunteers from the UK-based Fenland Study and evaluate clustering of TAGs in the National Survey of Health and Development...
Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsatur...
De novo lipogenesis (DNL) converts carbon substrates to lipids. Increased hepatic DNL could contribu...
Accumulation of hepatic lipids has been thought to trigger the inflammation, apoptosis, and fibrosis...
Abstract Background Diet is a major contributor to metabolic disease risk, but there is controversy ...
Background: Diet is a major contributor to metabolic disease risk, but there is controversy as to wh...
Hepatic steatosis is associated with poor cardiometabolic health, with de novo lipogenesis (DNL) con...
BACKGROUND: High-carbohydrate (HC) diets increase de novo lipogenesis (DNL), but effects on stearoyl...
BACKGROUND: Biomarker fatty acids (FAs) reflecting de novo lipogenesis (DNL) are strongly linked to ...
Background and Aims: Exaggerated hepatic triglyceride accumulation (i.e., hepatic steatosis) represe...
Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsatur...
Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsatur...
Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsatur...
lipogenesis (DNL) are strongly linked to the risk of cardiometabolic diseases. Liver fat accumulati...
Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsatur...
De novo lipogenesis (DNL) converts carbon substrates to lipids. Increased hepatic DNL could contribu...
Accumulation of hepatic lipids has been thought to trigger the inflammation, apoptosis, and fibrosis...
Abstract Background Diet is a major contributor to metabolic disease risk, but there is controversy ...
Background: Diet is a major contributor to metabolic disease risk, but there is controversy as to wh...
Hepatic steatosis is associated with poor cardiometabolic health, with de novo lipogenesis (DNL) con...
BACKGROUND: High-carbohydrate (HC) diets increase de novo lipogenesis (DNL), but effects on stearoyl...
BACKGROUND: Biomarker fatty acids (FAs) reflecting de novo lipogenesis (DNL) are strongly linked to ...
Background and Aims: Exaggerated hepatic triglyceride accumulation (i.e., hepatic steatosis) represe...
Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsatur...
Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsatur...
Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsatur...
lipogenesis (DNL) are strongly linked to the risk of cardiometabolic diseases. Liver fat accumulati...
Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsatur...
De novo lipogenesis (DNL) converts carbon substrates to lipids. Increased hepatic DNL could contribu...
Accumulation of hepatic lipids has been thought to trigger the inflammation, apoptosis, and fibrosis...